Wegovy and Ozempic are two medications that belong to the same class of drugs called GLP-1 agonists. These drugs are used to treat obesity and type 2 diabetes. According to the sources provided, the price difference between Wegovy and Ozempic varies depending on the pharmacy and the type of insurance coverage.
Drugpatentwatch [1] reports that Wegovy's patent is set to expire in 2039, while Ozempic's patent is set to expire in 2030. This suggests that Ozempic may be available as a generic medication sooner than Wegovy, which could potentially make it more affordable.
GoodRx [2] provides a comparison of the prices of Wegovy and Ozempic at various pharmacies. According to their data, the average retail price for a 4-pack of Wegovy pens (4.5 mg) is around $1,364, while the average retail price for a 4-pack of Ozempic pens (0.5 mg or 1 mg) is around $1,248. However, these prices can vary significantly depending on the pharmacy and the type of insurance coverage. GoodRx also notes that both medications may be eligible for savings programs and discounts.
UCHealth [3] notes that both Wegovy and Ozempic are relatively expensive medications, and that insurance coverage may play a significant role in determining the out-of-pocket cost for patients. They suggest that patients should talk to their healthcare provider and insurance company to determine the most cost-effective option for their individual needs.
In conclusion, the price difference between Wegovy and Ozempic varies depending on the pharmacy and the type of insurance coverage. While Wegovy may be more expensive on average, both medications may be eligible for savings programs and discounts. Patients are advised to consult with their healthcare provider and insurance company to determine the most cost-effective option for their individual needs.
Sources:
[1] https://www.drugpatentwatch.com/p/tradename/WEGOVY
[2] https://www.goodrx.com/classes/glp-1-agonists/wegovy-vs-ozempic
[3] https://www.uchealth.org/today/wegovy-vs-ozempic-the-truth-about-new-weight-loss-drugs/